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 X-linked retinoschisis (XLRS) is one of the most com-
mon causes of juvenile macular degeneration in males [1],
with a worldwide prevalence of 1 in 15,000-25,000 men [2].
This X-linked trait affects only men; female carriers rarely
have vision morbidity [3,4]. XLRS is characterized by
microcystic-like changes of the macular region of the retina
and schisis, or splitting within the inner retinal layers, leading
to visual deterioration [5,6]. Peripheral retinal lesions are also
present in about 50% of cases [6]. The clinical course gener-
ally causes a moderate decrease in visual acuity [5], but more
advanced stages are complicated by vitreous hemorrhage, reti-
nal detachment (RD), and neovascular glaucoma [7], which
may induce severe loss of vision. Severely affected male in-
fants may be blind at birth from bilateral RD [5]. Approxi-
mately 50% of XLRS patients also have a decrease in visual
field. The brief-flash electroretinograms (ERGs) of most af-
fected males exhibit normal or near normal a-waves charac-
teristic of photoreceptor function but often substantially re-
duced b-waves, originating from inner retinal cell activity [8].
The gene responsible for XLRS was identified by posi-
tional cloning [9]. The XLRS1 or RS1 gene contains six ex-
ons that encode a small, 224-amino-acid protein, with an N-
terminal secretory leader peptide sequence [10,11] and a
discoidin domain in exons four to six that is highly conserved
across species [12]. Discoidin domains are found in a large
family of secreted or membrane-bound proteins and have been
implicated in cell adhesion and cell-cell interactions [13]. Nu-
merous disease-causing mutations in RS1 gene have now been
recognized [14] (DMD).
The majority of these are missense mutations, although
nonsense mutations, deletions, insertions, and splice site mu-
tations have all been found. The correlation between the phe-
notype and genotype of XLRS remained unclear according to
the reports [15,16]. The clinical features in families from sev-
eral countries with defined mutations in the RS1 gene have
been reported [3,17-20].
In this study, we describe Chinese patients who have mu-
tations in their RS1 gene, and we examine their genotype-phe-
notype correlations. Four of these mutations have not been
previously reported.
METHODS
Clinical studies:  The research protocol was approved by the
ethics review board of the Peking University School of Medi-
cine. The study procedures were carried out in accordance with
institutional guidelines and the Declaration of Helsinki.
Twelve families with XLRS (Figure 1) were recruited for
this study. Ophthalmic examinations were performed in 29
affected males, 38 heterozygous females carriers, and 100
controls (with normal vision and without any eye diseases
male, not the members of XLRS families). The mean age was
27 years (SD 19) for the males, 45 years (SD 11) for the fe-
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804males, and 33 years (SD 16) for the controls. The examina-
tions included best-corrected visual acuity (BCVA), slit lamp
biomicrocopy, fundus examinations and photography, fluores-
cein angiography, A and B scan, standardized echography,
optical coherence tomography (OCT) and single-flash elec-
troretinograms (ERG). ERG results from the XLRS patients
were compared with those of 48 male controls (48 controls
for ERG examination) subjects with normal vision, whose ages
ranged from 11-43 years (mean age 32 years with SD 15).
The “reduced” ERG b-wave defined as values below mean-2
SD of controls values. The diagnostic criteria in XLRS1 male
patients included macular abnormalities defined as typical
foveal schisis, blunted foveal reflex, pigmentary demarcation
lines or retinal pigment atrophy with or without peripheral
retinoschisis (RS), reduced ERG b-wave, and a history of bi-
lateral visual impairment since childhood [1,5]. To examine
the relationship between axial length and refractive error in
patients with X-linked retinoschisis. The axial length and re-
fractive error were measured in 51 eyes of 29 patients. The
patients were divided into two groups: a juvenile group with
ages <13 years (9 eyes) and an adult group with ages greater
than or equal to 13 years (42 eyes). The axial length of the 40
eyes of 40 adult men without eye diseases whose refractive
error ranged from ±1.0 diopter served as controls.
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Figure 1. Pedigrees of families
with X linked juvenile
retinoschisis and identified
mutations in the RS1 gene.
Dark-shaded boxes represent
family members with X-linked
juvenile retinoschisis, while
light-shaded boxes and circles
mark those with nondisease-
related polymorphisms.
Circles with a dot denote obli-
gate carriers. Arrows point to
probands. Slashed circles or
boxes are deceased family
members.
805Molecular genetic studies:  Informed consent allowing
blood and eye examination was obtained from all subjects.
Genomic DNA was isolated from peripheral white blood cells
using a Blood DNA Isolation Kit, PureGene (Gentra Systems,
Minneapolis, MN), which was used as the template to am-
plify the RS1 gene. All primers were procured from Sigma
Genosis (Dalian, China). All exons (exon one to six) of the
RS1 gene were amplified by polymerase chain reaction (PCR)
using previously reported primers [9]. PCR products were
purified with QIAquick PCR Purification Kit (Qiagen K.K.,
Dalian, China) and used as the template for sequencing. Puri-
fied PCR products were sequenced on an automated sequencer
(ABI Prism 3100 Genetic Analyzer, Applied Biosystems;
Takara Co., Dalian, China).
RESULTS
 Eleven different RS1 mutations were identified in the 12 par-
ticipating XLRS families (Table 1). Eight of these mutations
were missense mutations, and nine were clustered in exons
four, five, and six encoding the discoidin domain. One frame-
shift mutation (26 del T) in exon 1 (Patients 90, 91, 92, 93),
and one rare splice donor site mutation (IVS1+2T to C) of the
exon 1 and intron 1 junction (Patient 330) were also identi-
fied: patients with these two mutations had severe clinical fea-
tures. To the best of our knowledge, four of these mutations
have not been previously described, namely, Asp145His,
Arg156Gly and frameshifting deletion (26delT, 488 del G)
mutations of exon 5.
The clinical data of patients are reported in Table 2. In the
29 XLRS male patients, the mean age at disease onset was 5.5
(SD 1.4) years, and the initial symptoms were photophobia,
squint, nystagmus, and reduced visual acuity (VA). In a few
cases, the patients were asymptomatic and diagnosed after
ophthalmological examination. BCVA varied from 20/20 to
light perception; the refractive spherical errors (see Table 3)
ranged from -7.25 to +7 diopters with mean values of +0.89
(SD 2.71). Hypermetropia in our patients, as with other stud-
ies [6,21,22], was the most frequent refractive error; the mean
value of the axial length calculated with immersion standard-
ized A-scan echography was 21.9 (SD 1.7).
Ophthalmoscopy revealed a marked interfamilial and
intrafamilial variability of the fundus (Figure 2, Figure 3, and
Figure 4). All but one (Patient number 142) had foveal RS.
Vitreo-retinal abnormalities included vitreous veils in 25 eyes
(49.0%), vitreoretinal tractions in 28 eyes (54.9%), and falci-
form folds in six eyes (11.5%). Macular abnormalities were
present in all affected patients except one (Patient 142). All
but one patient (patient 142) showed a typical foveal schisis, a
cystic-like stellate alteration. In addition, ophthalmic exam
revealed macular atrophy in ten eyes (19.6%), macular scar-
ring in eight eyes, and healthy macula in three eyes. Macular
abnormalities were not related to any genotype. The presence
of bone spicule pigmentation was evident in 13 eyes (25.5%).
Peripheral RS was evident in the temporal sector in 26 of the
51 eyes studied (51.0%). RD was present in 23 of the 26 eyes
(88.5%) while vitreous hemorrhage was seen in seven (13.7%).
There were 25 (49.0%) severe RS eyes with peripheral
retinoschisis, RD and vitreous hemorrhage. Strabismus and
neovascular glaucoma was seen in five (right eye of patient
310, both eyes of patient 380, both eyes of 240) and two eyes
(one eye of patient 90 and patient 20), respectively. Two eyes
from two patients were enucleated because of neovascular
glaucoma secondary to RS with proliferative vetroretinopathy.
These two patients came from families (pedigree 20 and 90)
who had the Arg209His and frameshift (26 del T) mutations,
respectively. Most of the male patients came to our depart-
ment with poor visual acuity from RD. These patients also
had vitreous hemorrhage, or strabismus and were seeking sur-
gical treatment. Among the total 29 male patients, the five
male patients (ten eyes) with poor VA were once misdiagnosed
for amblyopia (two eyes), cataract (one eye), retinal detach-
ment (five eyes) without RS, and other fundus diseases (two
eyes).
ERG was performed on 14 patients (Table 4). In all pedi-
grees the typical response to white single flash was a reduc-
tion of the b-wave amplitude and a relative preservation of
the a-wave amplitude, causing a reduced the ratio of ampli-
tude of b-wave to a-wave (b/a) ratio. The b/a ratio was re-
duced (<1.2) in 12 patients (85.7%) while two patients (14.3%)
had a reduction in both the a-wave and b-wave amplitudes,
with a normal b/a ratio. Moreover, the amplitude of the α-
wave was reduced in four RD patients. This reduction did not
appear to be related to disease duration. The maternal grand-
father (Patient 142) of proband (Patient 140), had normal b-
wave and a-wave amplitude, showing a normal b/a ratio of
2.2, and also normal fundus appearance, but had the Arg200Cys
mutation of exon 6.
DISCUSSION
 Many mutations in the RS1 gene have been identified [14,23-
26], but there are limited clinical data relating to the different
genotypes [14,21,27]. This study examined RS1 gene muta-
tions from Chinese families and the report regarding evalu-
ated genotype-phenotype correlation on RS1 in Chinese pa-
tients. We found four mutations and one non-disease-related
polymorphisms (NSP) not previously described [14].
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TABLE 1. IDENTIFICATION OF X LINKED JUVENILE RETINOSCHISIS 1
MUTATIONS IN THE X-LINKED JUVENILE RETINOSCHISIS PEDIGREES
Pedigree   Exon   Mutation    Predicted amino acid change   Predicted effect
--------   ----   ---------   ---------------------------   -----------------
90         1      26delT      frameshifting deletion        frameshift*
330        IVS1   52+2>T-C    Del                           splice donor site
280        4      217T>C      Ser73Pro                      missense
310        4      305G>A      Arg102Gln                     missense
60         5      433G>C      Asp145His *                   missense
380        5      466G>A      Arg156Gly *                   missense
190        5      488delG     frameshifting deletion        frameshift*
140        6      576C>T      Pro192Pro*                    NSP
140        6      598C>T      Arg200Cys                     missense
20         6      626G>A      Arg209His                     missense
240        6      638G>A      Arg213Gln                     missense
210        6      638G>A      Arg213Gln                     missense
350        6      667T>C      Cys223Arg                     missense
Summarized are the DNA outcome of RS1 mutations in Chinese X
linked juvenile retinoschisis pedigrees. The following abbreviations
were used: Ser is serine (Ser), Pro is proline (Pro), Arg is arginine
(Arg), Gln is glutamine (Gln), Asp is aspartic acid (Asp), His is his-
tidine (His), Gly is glycine (Gly), Trp is tryptophane (Trp), Cys is
cysteine (Cys), and NSP is non-disease-related polymorphisms (NSP).
The asterisk (*) indicates new mutation.
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TABLE 2. CLINICAL DATA OF X LINKED JUVENILE RETINOSCHISIS FAMILIES
    Pedigree                             Age at                        spherical    Axial
----------------                 Age      onset                          error     length   Vitreous abnormalities     Macular         Peripheral       Retinal
Number   Subject   Mutation    (years)   (years)   R/L      VA            (D)       (mm)       Ophthalmoscopy        abnormalities       RS            detachment
------   -------   ---------   -------   -------   ---   -----------   ---------   ------   ----------------------   ---------------   ----------   ----------------
90       90        L9CfsX20*     17         4       R    enucleation                                                                                NVG before
                                                                                                                                                    enucleation
                                                    L    20/200        +3.25        21.6    vitrectomy               foveal schisis       yes       PVR+ VH
         91        L9CfsX20*     62         5       R    Hm            +5           21.3    vitreoretinal traction   retinal pigment      yes       severe PVR,
                                                                                            falciform fold,          macular atrophy,               VH+ strabismus
                                                                                                                     bone spicule
                                                                                                                     pigmentation
                                                    L    FC            +1           20.7    vitreoretinal traction   retinal pigment      yes       severe PVR,
                                                                                                                     atrophy,                        VH
         92        L9CfsX20*     55         6       R    20/100        +1.5         --      vitreoretinal traction   foveal schisis       yes       yes
                                                    L    20/100        +0.75        --      vitreoretinal traction   foveal schisis       yes       yes
         93        L9CfsX20*     50         5       R    20/40         +0.5         23.4    vitreoretinal traction   foveal schisis       yes       no
                                                    L    20/100        +0.75        22.1    Vitreoretinal traction   foveal schisis       yes       yes
                                                                                            falciform fold,          macular atrophy,
                                                                                                                     pigmentation
330      330       52+2 T->C     19         6       R    20/200        -7.25        24.1    vitreoretinal traction   foveal schisis,      yes       RD+PVR+ VH
                                                                                            falciform fold,          bone spicule
                                                                                                                     pigmentation
                                                    L    20/200        -7           24.5    vitreoretinal traction   retinal pigment      yes       yes
                                                                                            falciform fold           atrophy,
                                                                                            vitreoretinal traction   pigmentation
280      280       Ser73Pro      20         6       R    20/40         +1           22.6    falciform fold,          foveal schisis       no        no
                                                    L    20/40         +1           22.2    falciform fold,          vitreoretinal        no        no
                                                                                                                     foveal schisis
                                                                                            vitreous veils           traction
         281       Ser73Pro      21         6       R    20/60         +2           22.0    vitreous veils                                no        no
                                                    L    20/40         +1.75        22.3    vitreous veils           foveal schisis       no        no
310      310       Arg102Gln     15         4       R    NLP           +0.50        22.6    vitrectomy               --                   yes       RD+ surgery
                                                                                                                                                    (1994) eye
                                                                                                                                                    atrophy+ strabismus
                                                    L    20/100        -1.50        23      Vitreoretinal traction   foveal schisis       yes       RD+PVR+ VH
                                                                                                                     retinal pigment                + strabismus
                                                                                                                     atrophy
60       60        Asp145His*    16         4       R    20/100        +3           21.6    vitreous veils,          foveal schisis       yes       Yes
                                                                                            vitreoretinal traction   pigmentation
                                                    L    20/50         +1.50        22.7    vitreous veils,          foveal schisis       yes       no
                                                                                            vitreoretinal traction
190      190       Trp163X*      9          4       R    20/50         +6           20.4    vitreous veils           foveal schisis       no        no
                                                    L    20/50         +7           20.5    vitreous veils           foveal schisis       no        no
140      140       Arg200Cys     5          4       R    20/30         +0.5         21.5    vitreous veils           foveal schisis       no        no
                                                    L    20/30         +0.5         21.3    vitreous veils           foveal schisis       no        no
         141       Arg200Cys     32         --      R    20/20         --           --      --                       --                   no        no
                                                    L    20/20         --           --      --                       --                   no        no
         142       Arg200Cys     67         --      R    20/20         --           23.0    no                       no                   no        no
                                                    L    20/20         --           23.0    no                       no                   no        no
20       20        Arg209His     4          2       R    20/100        +3           20.5    vitreous veils           foveal schisis       yes       RD+ PVR+ VH
                                                    L    enucleation   --           --       --                      --                   --        NVG after
                                                                                                                                                    virectomy
         21        Arg209His     21         5       R    20/50         -2           23.0    vitreous veils           foveal schisis       no        no
                                                    L    20/100        -4           23.5    Vitreoretinal traction   foveal schisis       no        no
         22        Arg209His     16        --       R    20/500        --           23.9    Vitreoretinal traction   foveal schisis       yes       yes
                                                    L    20/200        --           22.5    vitreous veils           foveal schisis       yes       yes
                                                                                            retinal traction
240      240       Arg213Gln     18         4       R    20/60         +4           20.9    Vitreoretinal traction   foveal schisis       yes       yes+ nystagmus
                                                                                                                     Bone spicule
                                                                                                                     pigmentation
                                                    L    FC            +4.5         20.6    Vitreoretinal traction   foveal schisis,      yes       RD+ VH+
                                                                                                                                                    nystagmus
                                                                                                                     retinal pigment
                                                                                                                     atrophy
         241       Arg213Gln     9          5       R    20/90         +2.0         20.9    Vitreoretinal traction   foveal schisis       yes       yes
                                                                                                                     Bone spicule
                                                                                                                     pigmentation
                                                    L    20/60         +1.0         20.0    vitreoretinal traction   foveal schisis,      yes       yes
                                                                                            falciform fold,          Bone spicule
                                                                                                                     pigmentation
         242       Arg213Gln     19         5       R    20/90         +3.0         21.0    vitreous veils,          foveal schisis        yes      yes
                                                                                            vitreoretinal traction   macular atrophy
                                                                                            falciform fold,
                                                    L    20/100        +4.0         20.8    vitreous veils,          foveal schisis        yes      yes
                                                                                            retinaltraction          macular atrophy
210      210       Arg213Gln     15         4       R    20/100        +0.5         21.3    vitreoretinal traction   foveal schisis        yes      yes
                                                    L    20/100        +1           21.0    vitreoretinal traction   foveal schisis        yes      yes
         211       Arg213Gln     27         --      R    20/60         +1.5         21.5    vitreoretinal traction   foveal schisis        yes      no
                                                    L    20/60         +1           21.2    vitreoretinal traction   foveal schisis        yes      no
350      350       Cys223Arg     29         6       R    20/40         -2.5         23.2    vitreous veils           foveal schisis        no        no
                                                    L    20/60         -4.0         23.5    vitreous veils           foveal schisis        no        no
         351       Cys223Arg     79         --      R    20/80         +1.5         22.2    vitreous veils           foveal schisis        no        no
                                                    L    20/80         +1           22.5    vitreous veils           foveal schisis
380      380       Arg156Gly     22         7       R    20/100        +0.5         20.4    vitreoretinal traction   foveal schisis        no        no,+ strabismus
                                                    L    20/50         +1.5         20.2    vitreous veils           foveal schisis        no        no,+ strabismus
         381       Arg156Gly     35         6       R    20/50         +1.5         -       vitreous veils           foveal schisis        no        no
                                                                                                                     pigmentation
                                                    L    20/50         +1.0         -       vitreous veils           foveal schisis        no        no
                                                                                                                     pigmentation
         382       Arg156Gly     29         5       R    20/40         -1.0         -       vitreous veils           foveal schisis        no        no
                                                    L    20/50         +0.5         -       vitreous veils           foveal schisis        no        no
         383       Arg156Gly     30         7       R    20/40         +1.0         -       Vitreoretina  traction   foveal schisis        no        no
                                                    L    20/30         +0.5         -       Vitreoretinal traction   foveal schisis        no        no
         384       Arg156Gly     19         6       R    20/40         +0.5         -       vitreous veils           foveal schisis        no        no
                                                    L    20/30         -0.5         -       vitreous veils           foveal schisis        no        no
Summarized are the clinical data corresponding to different RS1 mutations in Chinese X linked juvenile retinoschisis pedigrees. RS indicates
retinoschisis and PVR refers to proliferative vitreoretinopathy. VH represents vitreous hemorrhage; RD represents retinal detachment; NVG
represents neovescular glaucoma; PVR represents proliferative vitreoretinopathy. Blank sections means no data available.
807In the novel frameshift mutations (26 del T) of pedigree
90 XLRS family, we observed typical foveal RS with bilat-
eral peripheral RS in all four affected male patients of this
family, and with RD in seven of the eight eyes of these four
male patients. The mutation of 26 del T of exon 1, cause the
frameshift mutations from amino-acid 9 (L9C), loss of a 115
amino acids long fragment at C-terminus and synthesis of an
aberrant peptide from amino acid 9 to 114 followed by a pre-
mature stop, which caused the dramatic change of structure
with severe type of RS. One rare splice donor site mutation
(IVS1+2T to C) at the junction of exon 1 and intron 1 was
also identified in this study. The patient (Patient 330) had se-
vere foveal and peripheral RS and RD in both eyes, which
required surgical intervention. A T-to-C substitution at the 5'
splice donor site of intron 1 would be expected to completely
block the splicing of intron 1 from the primary transcript, thus
preventing formation of functional mRNA. This splice donor
site mutation would also be expected to produce only severely
truncated proteins without normal function, thus resulting in
severe clinical features we showed herein. Our results suggest
that severe cases of XLRS may be associated with upstream
mutations (exons 1-3) in the RS1 gene [18], which prevent
the formation of functional protein.
Families with either the Asp145His, Arg102Gln,
Arg209His and Arg213Gln mutations had clinically severe RS
features as compared to the genotypes of other mutations.
Patient 60, who had the Asp145His mutation, showed typical
foveal RS with peripheral RS in both eyes, and RD in the left
eye. This patient underwent vitrectomy with combined sclera
buckling. This patient with an Asp145His mutation of exon 5
showed severe RS with extensive retinal impairment. Both
Patients 20 and 22 from pedigree 20 with Arg209His muta-
tion had typical severe clinical feature with foveal RS, bilat-
eral peripheral RS and RD in both eyes, while Patient 21 from
the same family, had only mild foveal RS. The variation within
this family suggested that additional factors, perhaps other
genetic influences (i.e. unique environmental factors), might
contribute to disease severity.
In the family with another two novel mutations
(frameshifting deletion 488delG and Arg156Gly) and fami-
lies with Ser73Pro, Arg200Cys, and Cys223Arg mutations we
observed a mild RS clinical pictures compared with the geno-
types of other mutations. In the family (pedigree 280) with
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Figure 2. Fundus photographs and DNA sequence in Patient 20 of
Family 20.  Fundus of left eye (A) showing severe foveal and periph-
eral retinoschisis with tractional retinal detachment and proliferative
vitreoretinopathy. DNA sequencing examination revealed Arg209His
mutation -626G->A of exon 6 in normal control (B) and Patient 20
(C).
TABLE 3. THE MEANS AND STANDARD DEVIATIONS OF THE REFRACTIVE
ERROR AND AXIAL LENGTH IN EACH GROUP REFRACTIVE ERROR AXIAL
LENGTH
                                   Refractive    Axial length
       Subjects group              error (D)       (mm)
-------------------------------   -----------   ------------
All patients (51 eyes)            0.89±2.71     21.93±1.67
Juvenile patient group (9 eyes)   2.86±2.67     21.28±1.23
Adult patient group (42 eyes)     0.55±2.61*    22.11±1.10*
Normal adult group (40 eyes)      -0.26±0.64*   23.83±0.53*
Table summarizing refractive data and axial length of Chinese X
linked juvenile retinoschisis families. Asterisk is p<0.01 Mann-
Whitney U-test. Axial length in each group refractive error repre-
sents D and axial length represents mm.
808Ser73Pro mutation, we evidenced the typical mild type of RS.
But unlike reported by Hayashi et al. [27] that the same
Ser73Pro mutation with severe clinical feature of XLRS in a
Japanese patient, suggesting a variation of interfamilial phe-
notype with the same mutation. The phenotype associated with
the Cys223Arg genotype showed a similar mild clinical pic-
ture in proband and his maternal grandfather. The RS1
discoidin domain, which extends from amino acids 63-219
[14], has been considered critical for RS1 function. This cys-
teine at 223 has not been observed in any of the other 28 known
discoidin domain-containing proteins. Thus the Cys223Arg
mutation does not appear to destroy the structure or function
of RS protein [11]. It is not yet clear whether the five residues
in the extreme carboxyl terminal region of the protein are an
integral part of the discoidin domain or whether they contrib-
ute in some other fashion to RS1 protein interactions.
ERGs in juvenile XLRS has been shown to manifest a
reduction in b-wave amplitude and a relative preservation of
the a wave on single white-flash stimulation, leading to a re-
duction in the b/a ratio. In this study, the b/a ratio was in the
lower range, or was less than the b/a ratio in normal subjects.
Patient 142 had a b/a ratio higher than 2.0. This patient had
subtle macular changes as well and would have been hard to
diagnose had it not been for our molecular genetics studies,
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Figure 3. Fundus photographs and DNA sequencing in Patient 60 of
Family 60.  Fundus of right eye (A, B) showing cystoid-like
maculopathy and peripheral retinoschisis. The left eye underwent
vitrectomy with comobined sclera buckling because of retinal de-
tachment and vitreous hemorrhage (C). Peripheral retinoschisis was
found during the operation. DNA sequencing showed missense mu-
tation -433G->C, Asp 145 His of exon 5 in normal control (D) and
Patient 60 (E).
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Figure 4. Fundus photographs, optical coherence tomography im-
ages, and DNA sequencing in Proband 140, and his grandfather, (Pa-
tient 142) of Family 140.  The fundi of right (A) and left (B) eyes of
Patient 140 showing cystoid-like maculopathies and golden-yellow
reflex. Optical coherence tomography images of his right (C) and
left (D) eyes revealed splitting had occured in the inner retina around
the fovea. A normal fundus appearance (E) can be seen in his grand-
father (Patient 142) with the same mutation. When ompared with the
normal control (F), DNA sequencing showed the Arg200Cys muta-
tion (598C->T) of exon 6 in Proband 140 (G).
810which confirmed mutations in the RS1 gene.
Flash ERG produced a negative response in all patients
examined except for patient 142 who had minor macular
change. Miyake and colleagues [28] reported that, despite a
reduced b-wave, the a-wave was normal in early stages of
XLRS, whereas it was reduced in later stages. They suggested
that photoreceptors were not the primary target in the patho-
genesis of this disease. However, in our study, patients 330
and 310 who were 19 years old and 15 years old, respectively,
showed reduction in their a-waves and b-waves. Both these
males had peripheral RS with RD. It is possible that early pro-
gression of disease in these patients is related to the particular
mutations, in their RS1 gene. We further noticed that Patient
142, who was 67 years old had mild RS as evidenced by fun-
dus appearance and normal ERG recordings. Thus, our re-
sults suggest that these variations seem to be partially inde-
pendent of patient age. Moreover, the severity of the RS phe-
notype is partially related to the particular mutation and the
position of the mutation of the RS1 gene. Surprisingly, the
results of the flash ERG were relatively correlated with the
severity of the clinical feature of XLRS in all our affected
male patients. Thus, the ERG should be considered crucial for
diagnosis XLRS disease.
The individuals in our study appeared to be more severely
affected as compared with other reported cases. The reason
for this is that most patients were referred to us for surgical
treatment, for RD, as well as vitreous hemorrhage, or had pro-
liferative vetroretinopathy, and many of them had been misdi-
agnosed earlier in their clinical course. Thus, when boys with
visual impairment undergo ophthalmologic examination, it is
important to complement it with a full-field ERG, since the
ophthalmoscopic appearance in XLRS is variable. The com-
bination of full-field ERG and molecular genetics makes clini-
cal diagnosis of XLRS possible early in the course of the dis-
ease.
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